New analyses highlight use of long-acting injectable Vocabria Rekambys (cabotegravir rilpivirine LA) in clinical trial and real-world populations, and the economic and public health impact ...

Despite years of campaigns aimed at dispelling such myths, a positive result can still result in job loss, divorce, eviction.

The sex of people living with HIV-1 infection, schistosome infection, or both, is a fundamental determinant of their clinical ...

Researchers assessed the safety and efficacy of first-line antiretroviral therapy with bictegravir plus emtricitabine and tenofovir alafenamide in Black patients with HIV.

This valuable study uses robust time-dependent microscopy assays to show that during HIV-1 infection, the viral accessory protein Vif causes cell cycle arrest during metaphase and not G2/M as ...

Herpesviruses are common co-pathogens in individuals infected with human immunodeficiency virus (HIV). Herpes simplex virus ...

Researchers examined the prevalence, severity, and predictors of anemia among adult patients with HIV infection receiving highly active antiretroviral therapy.

A new form of immune cell, known as the stem-like CD4 T cell, has been identified as playing a crucial role in fighting ...

Unlike progressors, people who experience the expected progression of HIV to AIDS, VNPs exhibit relatively stable CD4 + T ...

Anyone living with HIV, especially those with risk of complications of mpox, such as people with a CD4 count <350/mm3 ... while supplies last: San Francisco AIDS Foundation, Clinic at Strut: ...

HIV/AIDS is currently the eighth leading cause of death in Africa, accounting for almost five percent of all deaths in 2021. At that time, HIV/AIDS was not among the leading 20 causes of death in ...